couter

ABXAbacus Global Management, Inc.

FinancialsAsset Management & Custody Banks

Abacus Global Management, Inc. (ABX) sells alternative asset management services, primarily focused on longevity-linked products. The next catalyst is Oct 15, 2026 — Fall Actuarial Assumption & Longevity Review, which will test the company’s ability to navigate actuarial assumptions and longevity risk in its new interval fund, ABXGX.

  • ABX’s revenue surged 110.2% YoY to $251.61M in Q2 2026, with a net margin of 15.3%
  • The company operates with negative debt-to-equity (-28.37x) and a net loss in shareholders’ equity (-$18.39M)
  • ABX’s leverage is low, but its cash flow is constrained by the sector’s capital intensity

The Read

Historically, ABX’s merger-related catalysts have triggered strong bullish moves, exemplified by a nearly 20% surge on June 25, 2026, driven by favorable legal rulings and analyst upgrades, well above its typical ~11% median M&A move.
Oct 15, 2026 — Fall Actuarial Assumption & Longevity Review
Chart by TradingView

The schedule

  • Thu15Oct

    Annual review of actuarial assumptions and longevity estimates which directly impact core life insurance reserves.

  • Sun7Feb

    Q3 2026 financial results, with street focus on free cash flow generation and margin expansion.

  • Sun9May

    Full-year 2026 results and strategic guidance for 2027, including potential dividend hikes or buyback authorizations.

  • Sun8Aug

    Q1 2027 earnings print testing sustained growth momentum and long-term integration of the 2026 strategic M&A.

  • Sun7Nov

Past

  • Sun9Aug

    Actual outcome: Bear · $8.93 at outcome

    Abacus Global Management, Inc. (ABX) beat earnings expectations with an EPS of $0.0751 versus the estimate of $0.0751, but the stock fell 6.3% following the Q2 2026 earnings release. The decline was driven by negative legal developments, including the unsealing of key evidence in the defamation lawsuit against Coventry, which revealed misleading practices and raised concerns about regulatory and reputational risks.

    Q2 2026 earnings announcement. Focus on operating cash flow and top-line sustainability following the recent M&A.

  • Thu25Jun

    Actual outcome: Bull · $10.76 at outcome

    The stock surged past the bull target, driven by positive legal developments as a federal court allowed Abacus's defamation lawsuit against Coventry to advance. The denial of Coventry's motion to dismiss, coupled with a recent analyst upgrade, fueled strong upward momentum and heavy trading volume.

    Expected closure of the strategic M&A transaction guided for Q2 2026, alongside potential integration strategy updates.

  • Mon11May

    Actual outcome: Mixed · $9.38 at outcome

    Abacus Global Management reported mixed Q1 2026 results, with a slight EPS miss ($0.20 vs. $0.21 estimate) offset by a 35% year-over-year revenue jump to $59.4 million. However, the company addressed liquidity concerns by generating $91.7 million in operating cash flow and raising its full-year profit guidance, leading to a flat stock reaction as investors weighed the bottom-line miss against the strong operational outlook.

    Abacus Global Management reported mixed Q1 2026 results, with a slight EPS miss ($0.20 vs. $0.21 estimate) offset by a 35% year-over-year revenue jump to $59.4 million. However, the company addressed liquidity concerns by generating $91.7 million in operating cash flow and raising its full-year profit guidance, leading to a flat stock reaction as investors weighed the bottom-line miss against the strong operational outlook.